Retatrutide Side Effects Are Similar to Existing Diabetes and Obesity Injectables The most common side effects for retatrutide were: Nausea (16 to 27 percent of participants, depending on dosage, compared with 3.7 percent of those taking a placebo) Diarrhea (19 to 23 percent, compared with 5 percent taking a placebo) Vomiting (16 to 18 percent, compared with 2 percent taking a placebo) Nerve issues (2 to 4 percent, compared with none taking a placebo) Between 2 and 5 percent of participants on retatrutide stopped taking it before the trial ended, with a greater risk of stopping among those who took the highest dose
Depending on the form you take, it may take up to 20 weeks to titrate up to your final maintenance dosage
Those in the control group regained about double that amount
The marketing around 'take it whenever you want' exists because peptide suppliers don't want to complicate sales with dosing protocols
For example, people dont stop taking blood pressure medication once they reach their target numbers
My Experience with Cost Plus and How It Changed My Life When I entered the freelance world, I was paying out the wazoo for marketplace health insurance